Vaccines
2 July 2013
Bellerophon Project awarded EUR 5.5 million by EU to develop Staphylococcus aureus vaccine25 June 2013
Vical and Astellas Announce Initiation of Phase 3 Trial of ASP0113 Cytomegalovirus Vaccine19 June 2013
Vaxart’s Groundbreaking Tablet Influenza Vaccine Generates Protective Antibody Levels in Humans11 June 2013
Medicago Receives Authorization from Health Canada and Commences Phase II Clinical Trial for an H5N1 Vaccine6 June 2013
Medicago is First in the World to Report Positive Interim Results for its H7N9 Pre-Clinical Trial6 June 2013
Novavax Produces MERS-CoV Vaccine Candidate30 May 2013
New European Phase II Trial to Test Immunovaccine’s DPX-Survivac in Brain Cancer PatientsNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports